These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20737745)

  • 1. Opening and continuing the discussion on influenza vaccination timing.
    Ryan KJ; Rousculp MD
    Am J Manag Care; 2010 Aug; 16(8):628-9; author reply 629-30. PubMed ID: 20737745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cost-effectiveness of prophylaxis and treatment of influenza].
    Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing influenza--the case for immunizing children at school.
    School Nurse News; 2008 Nov; 25(5):9. PubMed ID: 19146061
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years.
    Prosser LA; Meltzer MI; Fiore A; Epperson S; Bridges CB; Hinrichsen V; Lieu TA
    Arch Pediatr Adolesc Med; 2011 Feb; 165(2):112-8. PubMed ID: 20921341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
    Nichol KL
    Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employees' willingness to pay to prevent influenza.
    Johnston SS; Rousculp MD; Palmer LA; Chu BC; Mahadevia PJ; Nichol KL
    Am J Manag Care; 2010 Aug; 16(8):e205-14. PubMed ID: 20690787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical economics in the field of influenza--past, present and future.
    Szucs TD
    Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic implications of influenza vaccination for adults with asthma.
    Trogdon JG; Nurmagambetov TA; Thompson HF
    Am J Prev Med; 2010 Nov; 39(5):403-10. PubMed ID: 20965377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of vaccination against influenza in healthy, working adults.
    Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaco-economics of anti-influenza vaccinations].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic prerequisites of active influenza prevention].
    Grześk G; Gałaj A; Korbal P; Durmowicz A; Szadujkis-Szadurski L; Borys D; Grześk E
    Med Pr; 2002; 53(4):329-32. PubMed ID: 12474413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of pandemic influenza: review of cost-effectiveness studies.
    Lugnér AK; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
    Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
    Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine cost-effective, but underused.
    Nurs Manage; 2002 Oct; 33(10):10. PubMed ID: 12408137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Not Available].
    Blank PR; Szucs TD
    Praxis (Bern 1994); 2017; 106(11):589-593. PubMed ID: 28537112
    [No Abstract]   [Full Text] [Related]  

  • 20. Influenza vaccination: cost-effective health care for the older adult?
    Hampson AW; Irving LB
    J Qual Clin Pract; 1997 Mar; 17(1):3-11. PubMed ID: 9107599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.